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Abstract
Background
Chemical exposures have been associated with a variety of health effects;
however, little is known about the global disease burden from foodborne
chemicals. Food can be a major pathway for the general population’s exposure
to chemicals, and for some chemicals, it accounts for almost 100% of
exposure. 
Methods and Findings
Groups of foodborne chemicals, both natural and anthropogenic, were
evaluated for their ability to contribute to the burden of disease.  The results of
the analyses on four chemicals are presented here - cyanide in cassava,
peanut allergen, aflatoxin, and dioxin.  Systematic reviews of the literature were
1 2-4,16 5 6,7
8 9 8 10 11
12 13 14 15 8
8 8 8 8,16,17
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
   Referee Status:
 Invited Referees
 version 1
published
03 Dec 2015
  1 2 3
report report report
 03 Dec 2015, :1393 (doi: )First published: 4 10.12688/f1000research.7340.1
 03 Dec 2015, :1393 (doi: )Latest published: 4 10.12688/f1000research.7340.1
v1
Page 1 of 14
F1000Research 2015, 4:1393 Last updated: 16 FEB 2016
F1000Research
, Children’s Hospital ofJonathan Spergel
Pennsylvania USA
, George WashingtonGeorge M. Gray
University, Milken Institute School of Public
Health USA
, Johns Hopkins UniversityMary A Fox
Bloomberg School of Public Health USA
Discuss this article
 (0)Comments
3
2
1peanut allergen, aflatoxin, and dioxin.  Systematic reviews of the literature were
conducted to develop age- and sex-specific disease incidence and mortality
estimates due to these chemicals.  From these estimates, the numbers of
cases, deaths and disability adjusted life years (DALYs) were calculated.  For
these four chemicals combined, the total number of illnesses, deaths, and
DALYs in 2010 is estimated to be 339,000 (95% uncertainty interval [UI]:
186,000-1,239,000); 20,000 (95% UI: 8,000-52,000); and 1,012,000 (95% UI:
562,000-2,822,000), respectively.  Both cyanide in cassava and aflatoxin are
associated with diseases with high case-fatality ratios.  Virtually all human
exposure to these four chemicals is through the food supply. 
Conclusion
Chemicals in the food supply, as evidenced by the results for only four
chemicals, can have a significant impact on the global burden of disease. The
case-fatality rates for these four chemicals range from low (e.g., peanut
allergen) to extremely high (aflatoxin and liver cancer).  The effects associated
with these four chemicals are neurologic (cyanide in cassava), cancer
(aflatoxin), allergic response (peanut allergen), endocrine (dioxin), and
reproductive (dioxin).
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Introduction
Chemicals in food are a worldwide health concern1. Foodborne 
chemicals, both natural and anthropogenic, have been a source of 
concern with respect to international trade2–8, and various articles 
in the scientific literature have reported the health risks of chemi-
cal food contaminants9–11. The Dutch National Institute for Public 
Health and the Environment (RIVM) found that chemicals in food 
contributed as much as infectious agents to the foodborne burden of 
disease in the Netherlands12.
In September 2006 the World Health Organization (WHO) organ-
ized a consultation to develop a strategy to estimate the global 
burden of foodborne disease13. The first meeting of the WHO Food-
borne Disease Burden Epidemiology Reference Group (FERG), 
convened in September 200714, was the first of several meetings15–17. 
The FERG includes three hazard-based task forces: Enteric Disease 
Task Force, Parasitic Disease Task Force, and the Chemical and 
Toxins Disease Task Force (CTTF). A Country Studies Task Force, 
a Source Attribution Task Force, and a Computational Task Force 
were subsequently added to FERG. In the current study, the CTTF 
reports the estimates of the burden of disease of four chemicals. 
Methods
At its first meeting, the CTTF identified groups of chemicals 
and toxins that are of highest priority in estimating the burden of 
foodborne disease. These included: 
	Elemental contaminants (e.g., lead, mercury, cadmium, man-
ganese, arsenic)
	Mycotoxins (e.g., aflatoxins, ochratoxins, fumonisins, 
trichothocenes)
	Food additives (e.g., sulphites, nitrites/nitrates, benzoic acid)
	Pesticides/residues (e.g., organophosphates, carbamates, 
DDT, pyrethrins)
	Organic industrial pollutants (e.g., persistent organic pollutants)
	Veterinary drugs/residues (e.g., antibiotics, hormones – but 
not antimicrobial residues)
	Seafood toxins (e.g., tetrodotoxin, ciguatera, shellfish toxins, 
DSPs, PSPs, histamines)
	Process contaminants (e.g., acrylamide, PAHs, choropropanol)
	Allergens (e.g., peanuts)
	Natural toxicants (e.g., cyanide in cassava, aminoglycosides)
	Radionuclides and depleted uranium
The hazards were ranked on (1) the severity of potential health 
effects, (2) the prevalence of exposure, and (3) the availability of 
data to make burden estimates. After considerable discussion, the 
final list of chemicals/toxins for which the CTTF believed that 
burdens could be estimated were aflatoxin, cyanide in cassava, pea-
nut allergen, dioxin and dioxin-like compounds, methylmercury, 
lead, arsenic, and cadmium. Only the results for aflatoxin, cyanide 
in cassava, peanut allergen, and dioxin are presented here. The 
results for the metals will be provided in a subsequent publication.
For each of the four chemicals, a systematic literature review 
was conducted. It was concluded that burden estimates could be 
developed for (1) cyanide in cassava and konzo; (2) peanut allergy; 
(3) aflatoxin and hepatocellular carcinoma (HCC); and (4) dioxin 
and hypothyroidism; and (5) dioxin and decrease in sperm count. 
The methodology employed for each is described below. Additional 
information may be found in the Supplementary material. 
The metrics used to express burden are those of the WHO19. DALYs 
are the sum of years lived with disability (YLD) and years of life 
lost (YLL)18. YLD are estimated from the number of incident cases 
multiplied by the disability weight (DW) assigned to the disease 
and the duration of the disease from onset until remission or death18. 
YLL are estimated from the number of deaths, the distribution of 
age at death, and life expectancy18. The life expectancy used for the 
calculations is the projected life expectancy for the year 2050. Esti-
mates of the number of incident cases were produced using United 
Nations country-level population data for 2010 using the 2012 
Revision of World Population Prospects. Uncertainty around input 
parameters was estimated using Monte Carlo simulations; 10,000 
samples from each input parameter were used to calculate 10,000 
estimates of cases, deaths or DALYs. The 2.5th and 97.5th percen-
tile of each set of the 10,000 estimates yielded a 95% uncertainty 
interval (UI) which is presented around the median19. Detailed infor-
mation on the input parameters used in the DALY calculations for 
the different hazards is provided in the Supplementary material.
Cyanide in cassava
Cassava is an important staple for over 800 million people in 
approximately 80 countries, mostly in sub-Saharan Africa but also 
in Asia, the Pacific, and South America20. Cassava tubers contain 
a varying quantity of cyanogenic glucosides which protect the 
root against attack by animals and insects. Appropriate processing 
before consumption can reduce cyanogenic glucoside content of 
cassava. When high cyanogenic cassava is not processed correctly, 
high dietary cyanide exposure occurs. This often happens during 
times of famine and war. Cyanide in cassava is associated with 
acute cyanide poisoning and several diseases including konzo21. 
Worldwide reports exist of acute poisoning from cyanide in cas-
sava21 exist, but the data are inadequate to make burden estimates. 
The data are sufficient, however, to make burden estimates of konzo. 
Konzo is an irreversible spastic paraparesis of sudden onset, associ-
ated with the consumption of bitter cassava22,23 and a low protein 
intake24. It is a disease of extreme poverty. Konzo mostly occurs in 
epidemics, but sporadic cases are also reported. The case definition 
includes the following criteria: (1) a visible symmetrically spastic 
abnormality of gait while walking and/or running; (2) a history of 
abrupt onset (less than one week), followed by a non-progressive 
course in a formerly healthy person; (3) bilaterally exaggerated 
knee and/or ankle jerks without signs of disease in the spine24,25. 
Because konzo mostly affects remote rural areas where health infra-
structure is poor or non-existent, many cases remain undiagnosed 
or unreported, so the true burden of disease remains unknown. No 
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cases have been reported from urban areas. A total of 2376 konzo 
cases have been reported in 5 countries in Africa (Cameroon, 
Central African Republic, Democratic Republic of Congo [DRC], 
Mozambique, and United Republic of Tanzania)21, corresponding 
to 149 cases per year for 122 million people. Dividing the average 
annual number of cases for each country by the corresponding 
country population produces an observed incidence ranging from 
0.043 to 0.179 per 100,000. The degree of underestimation is 
difficult to determine as konzo occurs in rural areas, often under 
conditions of war, and the disease is not notifiable. The only reported 
calculation of underestimation was that of Tylleskar25 in the DRC 
in 1994, when he estimated that at least twice as many cases may 
have occurred as those reported. The underestimation in the DRC 
is likely to be much greater more recently, due to war and displace-
ment. It was therefore decided to account for the uncertainty in the 
underreporting by applying an expansion factor ranging uniformly 
from 1 to 10 to the observed cases. The mean annual incidence rate 
was therefore estimated as 0.9/100,000 (0.04 to 1.8/100,000). Our 
estimate of the burden of konzo is restricted to the 5 African coun-
tries described above and Angola. The decision to include Angola is 
based on a report to the World Congress on Neurology suggesting 
that cases have occurred in that country26. Although cassava con-
sumption occurs in tropical areas throughout the world, the term 
konzo has only been used to describe cases in Africa. The incidence 
of konzo in other countries in Africa and other parts of the world is 
assumed to be zero. 
We assumed the age of onset and gender distribution of these 
cases to be that observed by Tylleskar25. The konzo case-fatality 
ratio is approximately 21% based on four studies25,27–29. The age 
and gender distribution of fatal cases was assumed to be that of 
Tshala-Katumbay27. 
The onset of paraparesis in konzo is abrupt, usually within minutes 
or hours, with occasional progression during the first days of the 
illness. After that time, the paraparesis is non-progressive and per-
manent. As a result, duration is defined as lifelong for non-fatal 
cases. For fatal cases, it was assumed that death occurred one to 
seven years after onset, with a most likely value of three years after 
onset, following Banea et al.28 and Tylleskar et al.30. 
There is no DW specifically for konzo. The WHO defined three 
severity levels for konzo: (1) Mild = able to walk without support; 
(2) Moderate = uses one or two sticks or crutches to walk; and 
(3) Severe = not able to walk24. The Global Burden of Disease 
(GBD) 2010 DWs for mild, moderate, and severe motor impair-
ment are 0.012, 0.076, and 0.377, respectively31. The distribution 
of konzo severity among 753 patients from nine different studies 
were mild (63%), moderate (27%) and severe (10%)27,28,30,32–37. This 
distribution and the disability weights described above were used to 
assign a disability weight of 0.065 to konzo. 
Peanut allergen
Prevalence data on peanut allergy were used to make estimates of 
incidence since allergy occurs early in life (< 5years) and is believed 
to be lifelong38–42. All peanut allergy cases are assumed to be the 
result of eating peanuts or peanut products. In western countries, 
the prevalence of clinical peanut allergy in children is 0 to 1.8% of 
the population38, corresponding to incidence rates of 0 to 22.6 per 
100,000. Limited data exist on the mortality rate of peanut-induced 
anaphylaxis, but the majority of studies found similar rates, rang-
ing from 0 to 0.006 deaths per 100,000 person-years38. Incidence 
was estimated only for the WHO A level (high income) subregions; 
too few data exist to make estimates for other subregions38. Several 
studies have reported that 63–66% of cases are male38, but given the 
uncertainty in this number, the gender distribution was assumed to 
be equal for the burden of disease calculations. No DW exists for 
peanut allergy. Mullins et al.39 reported that 52% of cases referred 
to a specialist allergy medical practice in Australia suffered from 
mild symptoms (skin and subcutaneous tissue involvement only), 
42% from moderate symptoms (features suggestive of respiratory, 
cardiovascular or gastrointestinal involvement), and 6% from severe 
symptoms (cyanosis, hypotension, confusion, collapse, loss of con-
sciousness, incontinence). We propose the DW for peanut allergy be 
a weighted average accounting for this severity distribution. GBD 
2010 DWs31 for the health states defined in the category “Asthma: 
controlled” (DW=0.009) are considered applicable for mild and 
moderate cases (94%), and “Generic uncomplicated disease: anxi-
ety about the diagnosis” (DW=0.054) for severe cases (6%), because 
anxiety is known to impact quality of life in food allergic patients43, 
leading to a severity-weighted DW of 0.012 for clinically relevant 
peanut allergy. Unlike other childhood allergies such as cow’s milk 
and egg allergy, peanut allergy rarely resolves44,45.
Aflatoxin
Aflatoxins are secondary metabolites of the fungi Aspergillus 
flavus and A. parasiticus, and less frequently other Aspergillus 
species such as A. nomius46. These species can be found in maize, 
peanuts (groundnuts), oilseeds, and tree nuts in tropical and sub-
tropical regions46. It is believed that all aflatoxin exposure results 
from food consumption. We assumed a multiplicative model for the 
effects of aflatoxin exposure and hepatitis B virus (HBV) infection 
and estimated excess risk due to aflatoxin exposure as described 
by Liu and Wu46. To account for differences in background rates 
between the study population from which the cancer potency fac-
tor was derived47 and global populations, we estimated popula-
tion attributable fractions (PAFs) by country, and applied them to 
HCC incidence and mortality based on48,49. A Bayesian log-normal 
random effects model50 was used to extrapolate available PAFs 
to countries without data. Age-specific incidence estimates were 
derived from a study in China comparing age-specific incidence of 
HCC in Qidong, a city in China with high aflatoxin exposure, and 
Beijing, a city with low aflatoxin exposure51. The YLD and YLL 
envelopes for HCC that are available from WHO were multiplied 
by the proportion of the burden due to aflatoxin. Thus no DW was 
directly involved in the calculation.
Dioxin
Dioxins are mainly byproducts of industrial processes, but can also 
result from natural phenomena such as volcanic eruptions and for-
est fires. More than 90% of human exposure to dioxins is through 
the food supply. The foods most often associated with dioxin con-
tamination are meat, dairy products, fish, and shellfish52. Due to 
the bioaccumulation and lipophilic characteristics of dioxins, 
daily dietary exposure leads to accumulation of these compounds 
in human body fat. In adults this accumulation is thought to reach 
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a constant level (i.e., a steady state). Consequently, the dioxin body 
burden, rather than the daily exposure, is taken as the dose metric 
for chronic toxicity risk and the assessment of dioxins53–58. In this 
context the dioxin concentration in breast milk fat directly reflects 
the concentration in body fat58–61. 
Many national authorities have programs in place to monitor dioxin 
in the food supply and breast milk61–63. Dioxin-induced prenatal and 
postnatal hypothyroidism and prenatally induced reduced sperm 
production have been found to be the most sensitive non-cancer 
toxic endpoints for dioxins. Estimates for dioxin-induced prena-
tal and postnatal hypothyroidism and reduced fertility due to dis-
turbed sperm formation were based on an exposure assessment, 
toxicity assessment, and the comparison of both assessments64,65. 
The exposure assessment is based on breast milk concentrations 
of dioxin from 50 countries63. The toxicity assessment utilizes the 
benchmark dose (BMD) approach66–68 in which the dose response 
of postnatal total thyroxine (TT; decrease of TT4 in adult blood), 
prenatal thyroid stimulating hormone (TSH; increase in TSH in 
neonatal blood), and sperm production (reduced concentration of 
sperm cells) is analyzed. The toxicity and exposure assessments are 
compared to derive the transgression of a dioxin induced decrease 
in TT4, decrease in sperm cell count and increase in TSH across a 
physiological threshold indicating a disease status (i.e., incidence 
of hypothyroidism or impaired fertility). Additional details of these 
assessments may be found in Zeilmaker et al.69. The BMD analysis 
was performed on studies which served as the starting point for the 
derivation of a tolerable weekly intake (TWI)54–57 or reference dose 
for dioxin (RfD)58.
In a study of a mother-child cohort, Baccarelli et al. determined 
the relationship between maternal plasma dioxin concentra-
tion and TSH level70. A BMD analysis of these data resulted in a 
population distribution of the maternal body burden of dioxin cor-
responding to an increased TSH level of 5 µU/mL in offspring, 
a level not to be exceeded in 3% of newborns in iodine-replete 
populations71. 
Following administration of an acute oral dose to pregnant Long 
Evans rats on day 15 of gestation, Gray et al. measured the reduc-
tion in cauda epididymis sperm count in male offspring72. The 
resulting dose response data were used to calculate a BMD lower 
confidence limit (BMDL) and upper confidence limit (BMDU) 
dioxin body burden for various levels of reduction in sperm count. 
A WHO reference cut-off value for impaired fertility of 20 × 106 
sperm cells/mL was used to link toxicity (sperm count reduction) 
to a disease status (impaired fertility) (i.e., the calculation of the 
probability of a male being born with dioxin-impaired fertility)73. 
A BMD analysis of a National Toxicology Program (NTP) two year 
feeding study in rats was used to make estimates of dioxin-induced 
thyroid toxicity. The NTP study administered 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (TCDD)74 and 2,3,4,7,8-pentachlorodibenzo-
furan75 for periods of 14, 31, and 53 weeks. The concentrations 
were converted to toxic equivalent quotients76 to enable a combined 
analysis of both congeners. BMDL and BMDU body burdens for 
reduction in TT4 were calculated for each of the exposure periods. 
A distribution of TT4 in human blood has been reported by Aoki et 
al.71. The 5th percentile of this distribution (65 nmol/L) was used as 
the cut-off for overt clinical hypothyroidism in adults. 
The results of the BMD analyses and the breast milk concentra-
tions for 50 countries were compared, taking account of possible 
differences between experimental animals and humans and among 
individual humans64,65. This comparison provided country-specific 
estimates of the incidence of dioxin induced prenatal and postnatal 
hypothyroidism and impaired fertility. The estimates were extrap-
olated to other countries for which no breast milk concentrations 
were available by means of Bayesian random effects modeling50. 
Results
Dataset 1. Raw data for Gibb et al. 2015, ‘World Health 
Organization estimates of the global and regional disease 
burden of four foodborne chemical toxins, 2010’
http://dx.doi.org/10.5256/f1000research.7340.d107254 
A detailed description of the data can be found in the text file 
provided (‘Raw data legends’).
The analyses presented here show that four selected chemicals 
already have a substantial impact on the foodborne burden of disease, 
particularly in low- and middle-income countries. Just these four 
agents are estimated to be associated with 339,000 illnesses (95% 
UI: 186,000–1,239,000); 20,000 deaths (95% UI: 8,000–52,000); 
and 1,012,000 DALYs (95% UI: 562,000–2,822,000), respectively, 
in the year 2010. These should be considered the “tip of the iceberg” 
in terms of foodborne chemicals and their impact on the global 
burden of disease. For peanut allergens, we were unable to estimate 
a burden for low- and middle-income countries due to data gaps. 
We also had to use an approximate disability weight, as there are 
data only on quality of life of patients with food allergy38 and no 
specific data are available for peanut allergy.
The estimated number of incident cases, deaths, and DALYs of 
each of the diseases associated with chemicals is given in Table 1. 
The chemical associated with the most number of illnesses is 
dioxin; however, no deaths have been reported from the presence 
of dioxin in the food supply. The chemical associated with the 
greatest number of DALYs is aflatoxin. The DALY estimates for 
aflatoxin and dioxin have the least uncertainty; more uncertainty 
is associated with the DALY estimates for peanut allergen and 
cyanide in cassava. The annual incidence, mortality, and DALY 
rate of each chemical-associated disease per 100,000 population 
for each of the WHO regions is reported in Table 2. Peanut allergy 
is not reported in Table 2 because burden was estimated only for 
Americas Region A (AMR A) - United States, Canada, and Cuba); 
Europe A (EUR A) - primarily countries in western Europe; and 
Western Pacific Region A (WPR A) - Australia, Brunei Darussalam, 
Japan, and New Zealand. Burden estimates for cyanide in cassava 
are provided only for the African region (AFR) and assumed to be 
zero for other regions.
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Table 1. Median number of foodborne illnesses, deaths, and DALYs, with 95% UIs, 2010.
CHEMICAL FOODBORNE ILLNESSES (95% UI)
FOODBORNE DEATHS 
(95% UI)
FOODBORNE DALYS 
(95% UI)
Aflatoxin 21,757 (8,967–56,776)
19,455 
(7,954–51,324)
636,869 
(267,142–1,617,081)
Cyanide in cassava 1,066 (105–3,016)
227 
(22–669)
18,203 
(1,769–53,170)
Dioxin 193,447 (155,963–1,085,675
0 
(0–0)
240,056 
(192,608–1,399,562)
Peanut allergens* 107,167 (6,262–210,093)
28 
(2–56)
99,717 
(5,827–195,489)
TOTAL 338,611 (185,705–1,238,725
19,736 
(8,210–51,700)
1,012,362 
(562,087–2,822,481)
*Only the burden for AMR A, EUR A, and WPR A was assessed.
Table 2. Median rate per 100,000 foodborne illnesses, deaths, and DALYs by WHO region, with 95% UIs.
REGION
CHEMICAL
Aflatoxin Cyanide in Cassava Dioxin Total
AFRO
FB Illnesses (95% CI) 0.4 (0.1–1) 0.1 (0.01–0.4) 0.2 (0.07–7) 0.7 (0.3–8)
FB Deaths (95% CI) 0.4 (0.1–1) 0.03 (0.003–0.08) 0 (0–0) 0.4 (0.1–1)
FB DALYs (95% CI) 15 (5–40) 2 (0.2–6) 0.2 (0.07–8) 18 (7–49)
AMRO
FB Illnesses (95% CI) 0.08 (0.02–0.6) 0 (0–0) 0.2 (0.05–6) 0.2 (0.1–7)
FB Deaths (95% CI) 0.08 (0.02–0.6) 0 (0–0) 0 (0–0) 0.08 (0.02–0.6)
FB DALYs (95% CI) 2 (0.4–15) 0 (0–0) 0.2 (0.07–9) 2 (0.6–24)
EMRO
FB Illnesses (95% CI) 0.2 (0.04–0.5) 0 (0–0) 2 (1–35) 2 (1–35)
FB Deaths (95% CI) 0.1 (0.04–0.4) 0 (0–0) 0 (0–0) 0.1 (0.04–0.4)
FB DALYs (95% CI) 4 (1–13) 0 (0–0) 2 (2–43) 7 (3–51)
EURO
FB Illnesses (95% CI) 0.02 (0.01–0.03) 0 (0–0) 1 (0.7–13) 1 (0.7–13)
FB Deaths (95% CI) 0.02 (0.01–0.03) 0 (0–0) 0 (0–0) 0.02 (0.01–0.03)
FB DALYs (95% CI) 0.5 (0.3–0.8) 0 (0–0) 1 (0.9–19) 2 (1–19)
SEARO
FB Illnesses (95% CI) 0.2 (0.08–0.6) 0 (0–0) 9 (8–32) 10 (8–32)
FB Deaths (95% CI) 0.2 (0.08–0.5) 0 (0–0) 0 (0–0) 0.2 (0.07–0.5)
FB DALYs (95% CI) 7 (2–17) 0 (0–0) 12 (10–41) 19 (13–54)
WPRO
FB Illnesses (95% CI) 0.6 (0.1–2) 0 (0–0) 0.05 (0.005–4) 0.8 (0.1–5)
FB Deaths (95% CI) 0.5 (0.09–2) 0 (0–0) 0 (0–0) 0.5 (0.09–2)
FB DALYs (95% CI) 16 (3–63) 0 (0–0) 0.07 (0.007–6) 16 (3–65)
GLOBAL 
FB Illnesses (95% CI) 0.3 (0.1–0.8) 0.02 (0.002–0.04) 3 (2–16) 3 (3–17)
FB Deaths (95% CI) 0.3 (0.1–0.7) 0.003 (0–0.01) 0 (0–0) 0.3 (0.1–0.8)
FB DALYs (95% CI) 9 (4–24) 0.3 (0.03–0.8) 3 (3–20) 13 (7–39)
Figure 1 provides the DALYs per 100,000 inhabitants by global 
region. The regions with the highest burden per 100,000 inhabitants 
are the Southeast Asia Region (SEAR), Western Pacific Region 
(WPR), and the African Region (AFR). The AMR, Eastern 
Mediterranean Region (EMR), and EUR have the lowest DALYs per 
100,000. Aflatoxin is the largest contributor to the burden in AFR 
and WPR. Dioxin makes the largest contribution in SEAR. Figure 2 
contrasts the proportion of DALYs due to YLL and YLD for each 
of the four chemicals. Virtually all of the DALYs for aflatoxin and 
most of the DALYs for cyanide in cassava are due to YLL, whereas 
most of the DALYs for peanut allergen and all of the DALYs for 
dioxin are due to YLD. Figure 3 shows the uncertainty around the 
DALY estimates for each of the four chemicals. The chemical with 
the least uncertainty and the most number of DALYs is aflatoxin. 
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Figure 1. The relative contribution to the DALY incidence by each of four chemicals for each of the WHO regions.
Figure 2. The relative contributions from YLLs and YLDs for each of four chemicals.
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Discussion
The assessment of burden of disease from chemicals in the food is 
a challenge on several levels. There are thousands of chemicals in 
production and many naturally occurring toxins. How many of these 
chemicals and toxins make it into the food supply is unknown. The 
health effects of chemicals may not be observed for years follow-
ing exposure (e.g., aflatoxin and liver cancer, lead and cardiovas-
cular disease). Longitudinal studies of these effects are expensive 
and time-consuming. Sufficient information is available, however, 
to make estimates of the burden for arsenic, cadmium, methyl 
mercury, and lead and possibly for other chemicals and toxins 
(e.g., fish toxins, aristolochic acid). Other chemicals (e.g., persist-
ent organic pollutants) may not require elaborate epidemiological 
studies because the burden can be derived from biomonitoring data 
in combination with relevant toxicity data. Estimates of the bur-
den for these chemicals will provide a much more comprehensive 
understanding of the impact that chemicals in the food supply have 
on the burden of disease.
As the relevant disease endpoints due to foodborne chemicals 
may arise from different causes, various approaches are possible 
for estimating incidence and mortality. A “top-down” approach 
uses an existing estimate of morbidity or mortality of the disease 
endpoint by all causes (“envelope”) as a starting point. A popula-
tion attributable fraction is then calculated for the hazard under 
consideration, and applied to the envelope to estimate the hazard- 
specific incidence. This method, which is the standard in global 
burden of disease estimations, was used for aflatoxin. A “bottom-
up” or dose response approach uses dose-response and exposure 
Figure 3. DALY for each of four chemicals from contaminated food ranked from lowest to highest with 95% UI (The dot in the middle 
of each box represents the median, the box the 50% UI, the dark bar the 95% UI, and the light bar the 95% UI).
information. The approach begins with selection of the appropriate 
dose response relationship between the chemical and the particular 
disease. This dose response relationship is then combined with the 
distribution of exposure within a population to derive an estimate 
of the incidence of the disease that is attributable to the exposure. 
A probabilistic version of this method, which is applied in chemical 
risk assessment, was used for dioxin64,65. The two approaches would 
result in the same results if perfect data were available, and if it 
can be assumed that the risk of exposure to a chemical is additive 
to the background risk from other causes. In reality, the available 
data for both approaches are limited and there is insufficient infor-
mation to decide conclusively whether risks are additive, multipli-
cative or otherwise. This may result in considerable discrepancies 
between results from these methods. In this study, we chose a “top-
down” approach for aflatoxin because the cancer potency factor 
derived by the Joint FAO/WHO Expert Committee on Food Addi-
tives (JECFA)47 was based on a multiplicative model, and there is 
evidence for a high background rate in the study population under-
lying this estimate and the global population (see Supplementary 
material). Using the population attributable fraction approach, we 
estimated there were approximately 22,000 (95% UI 9,000–57,000) 
cases of aflatoxin-related HCC in 2010. A dose response approach46 
estimated that annually, 25,200–155,000 cases of HCC may be 
attributable to aflatoxin exposure. Even though the uncertainty 
intervals overlap, there is significant difference between these two 
approaches. There is evidence for a high background rate in the 
study population underlying this estimate and the global population 
(see Supplementary material), which may result in overestimation 
of mortality by the dose response approach. On the other hand, the 
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global liver cancer envelope may be underestimated, particularly in 
Africa77,78, leading to underestimation of the aflatoxin attributable 
incidence.
It is hoped that the presentation here will raise awareness among 
countries planning their own foodborne burden of disease assess-
ments to consider natural and anthropogenic chemicals. It is also 
hoped that this publication will lead to the development of chemical 
specific biomonitoring data to assess exposure and of epidemio-
logic data on other diseases associated with chemicals in food. 
Data availability
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For the estimate of Konzo , it was multiple by 10.  I would suggest a range as it is an estimate based on
poor reporting.  Is there another disease to model off to get a better range?
The rest of the article is acceptable.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 26 Jan 2016
, Gibb Epidemiology Consulting LLC, USAHerman Gibb
In the section on cyanide in cassava, a range of 1 to 10-fold was reported:  "It was therefore
decided to account for the uncertainty in the underreporting by applying an expansion factor
ranging uniformly from 1 to 10 to the observed cases." 
 There are no competing interests.Competing Interests:
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